Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.

Biotechnology

Kurome Therapeutics

Kurome Therapeutics' headquarters in Cincinnati, OH, United States

Jan Rosenbaum

Mehdi Shahidi

Paul Gaitan

Gregory Hayes

Mikkael A. Sekeres

Abram Gordon

Ross L. Levine

Daniel Heller

Shyam Masrani

Guillermo Garcia-Manero

Manish Bhandari

Daniel Starczynowski

John C. Byrd

Giovanni Mariggi

Governance and Oversight

Leadership Team

Research and Development

Kurome Therapeutics

Org chart

Board & advisors

Teams

Governance and Oversight

Leadership Team

Research and Development

Offices

Similar companies